Skip to content

Bismuth subsalicylate

Helidac (bismuth subsalicylate) is a small molecule pharmaceutical. Bismuth subsalicylate was first approved as Helidac on 1996-08-15. It is used to treat bacillary dysentery, diarrhea, dyspepsia, escherichia coli infections, and helicobacter infections amongst others in the USA.
Trade Name Helidac
Common Name Bismuth subsalicylate
Indication bacillary dysentery, diarrhea, dyspepsia, escherichia coli infections, helicobacter infections, nausea, stomach diseases, virus diseases
Drug Class Anti-inflammatory agents (salicylic acid derivatives)
Bismuth subsalicylate
Get full access now